New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 27, 2014
08:24 EDTFFIVF5 Networks risk/reward favorable, says Pacific Crest
Pacific Crest said its contacts indicate Cisco (CSCO) ACE replacement deals continue to drive healthy demand for F5 Networks's (FFIV) higher-end VIPRION platforms and new appliances. The firm said it now has increased conviction in shares of F5 and it keeps an Outperform rating on the name with a $133 price target. It views the risk/reward as favorable at current levels.
News For FFIV From The Last 14 Days
Check below for free stories on FFIV the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 20, 2014
10:04 EDTFFIVOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:32 EDTFFIVF5 Networks upgraded at ISI Group
As noted earlier, ISI Group upgraded F5 Networks to Strong Buy from Buy. The firm thinks the company's positioning vis-a-vis NFN/SDN has improved, while its momentum from a number of growth drivers, including security, has increased. The firm is now more confident that the company's EPS could approach $7 in 2015. Target $135.
August 19, 2014
21:06 EDTFFIVF5 Networks upgraded to Strong Buy from Buy at ISI Group
11:05 EDTFFIVImperva seen as takeover candidate under new CEO
Subscribe for More Information
08:42 EDTFFIVImperva new CEO has history of selling companies, says Sterne Agee
After Imperva (IMPV) appointed Anthony Bettencourt as its new CEO, Sterne Agee says that he has a history of selling companies. The firm believes that Imperva "would likely be an acquisition candidate" for a number of large tech companies such as Cisco (CSC), Juniper (JNPR), HP (HPQ), IBM (IBM), Check Point (CHKP), or F5 (FFIV). Sterne Agee believes that Imperva could be acquired for as much as $45 per share, and it keeps a Buy rating on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use